Fundraising FoxTabula Rasa Ventures
Venture capitalSeed · 14 people tracked
Find your way into Tabula Rasa Ventures
Sign up to find every way you can get introduced to Tabula Rasa Ventures
- Your email: who you already know at Tabula Rasa Ventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Tabula Rasa Ventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Tabula Rasa Ventures backs innovators building the future of human health as citizens increasingly lose trust in legacy institutions and gravitate toward alternatives. The firm believes that over the coming decade, technological innovation combined with disappointment in existing health systems will give rise to novel healthcare infrastructure built by exceptional founders. It emphasizes stakeholder alignment, building and preserving trust, principled yet adaptive founder behavior, and avoiding force in favor of patient, intentional building. The firm prioritizes patient access and a healthier, more peaceful humanity, seeking durable businesses structured to endure and scale to impact billions of lives.
Source: firm website, verified Oct 2, 2026.
Team · 14 people
from the firm's website & public directories
What they invest in
from 8 of 23 portfolio companiesHealthtech ×7Biotech ×4AI & Machine Learning ×3Deep Tech ×3Enterprise Software ×3Digital Health ×2Medical Devices ×2Data & Infrastructure ×1
HQs:United States×7
Investments · 23 tracked
founders shown can be your intro path
2AB BioscienceS develops first-in-class small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders.
BiotechDeep TechDigital HealthEdTechHealthtechMedical DevicesSanta Monica, US
Alex Speiser(Co-Founder & Chief Executive Officer)inCharles Nichols, PhD(Co-Founder & Chief Science Officer)David Nichols, PhD(Co-Founder & Head of Chemistry)Tim Foster, PhD(Co-Founder & Head of Translational Discovery)
BoardGopal Das(Director)
Co-investorsLIONHEART VENTURESPalo Santo VCWhat If Ventures
Amera Health Solutions provides a data integration platform that connects fragmented claims processing systems for health plans.
Data & InfrastructureEnterprise SoftwareFintechHealthtechInsurTechNew York City, US
Deep Kapur(Founder)inLouise Tanski(Founder)in
Co-investorsValia VenturesY CombinatorAlumni VenturesBase10 PartnersC Square CapitalComma Capital+7 more
CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.
BiotechHealthtechNew York City, US
David van Dijk(Co-Founder & CEO)inIvan Vrkic(Co-Founder)in
Co-investorsACVC PartnersPioneerY CombinatorZAKA VC0 ADBatch Ventures+12 more
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.
BiotechDeep TechMental Health
Co-investorsJourneyOne VenturesLauder PartnersLeafy TunnelSolari CapitalWGD Capital, L.P.XEIA Venture Partners
Opalite builds language interpretation technology for healthcare, enabling real-time communication between physicians and patients across language barriers.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Cathleen Kuo(Founder)inAlex Mehregan(Founder)in
Co-investorsSterling RoadY Combinator007 Venture PartnersCoyote VenturesDent CapitalHassan Lantry (Blast)+6 more
Rhizome AI provides an AI research platform that answers regulatory and clinical questions by citing documents from health authority databases across multiple markets, with built-in hallucination prevention.
AI & Machine LearningEnterprise SoftwareHealthtechNew York City, US
Chetan Mishra(Founder)in
Co-investorsY Combinator
Ruma provides prior authorization software for healthcare practices, helping clinics manage and scale authorization requests across multiple locations.
Enterprise SoftwareHealthtechSaaSSan Francisco, US
Meng Fei Shen(Founder)inChristina Huang(Founder)in
Co-investorsY CombinatorHassan Lantry (Blast)Rebel FundRobinhoodxfactor ventures
Strand AI predicts missing biological data modalities from existing patient data, converting single histopathology slides into spatial protein maps and inferring gene expression from genotype.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US
Yue Dai(cofounder ceo)inOded Falik(Founder)in
Co-investorsAkkaY CombinatorAndreessen HorowitzBain Capital Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
2AApolloBig Leap HealthDeepWell DTxEntheaLykos TherapeuticsNatural MedtechOlden LabsPsynauticsTerranTerran BiosciencesThe Synthesis InstituteWavepaths
Portfolio news
latest coverage across their companiesOpalite Health · techcrunch.com · Mar 26, 2026
Strand AI · ycombinator.com · Feb 25, 2026
CellType · ycombinator.com · Feb 17, 2026
Ruma Care · ycombinator.com · Jan 29, 2026
Rhizome AI · ycombinator.com · Jan 29, 2026
Amera · ycombinator.com · Nov 6, 2025
Frequently asked questions
- How many investments has Tabula Rasa Ventures made?
- Tabula Rasa Ventures has 23 tracked investments.
- What stage does Tabula Rasa Ventures invest at?
- Tabula Rasa Ventures invests at the Seed stage.
- What sectors does Tabula Rasa Ventures focus on?
- Tabula Rasa Ventures focuses on Digital Health, Enterprise Software, Fintech, Healthtech.